UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

PATH pushes deeper into agentic AI with open standards, new platform tools, and partners, but real payoff may depend on adoption speed and future pricing models.

Turning to its guidance, UiPath sees revenue of $395 million to $400 million for its fiscal Q1 2027. For the full fiscal year 2027, the company sees revenue of $1.754 billion to $1.759 billion, ...

UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

UiPath reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for ...

UiPath Inc PATH reported financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. Here’s a look at the key details from the report. UiPath shares are advancing ...

UiPath is expanding its partnership with Deloitte through the professional services company's new Agentic ERP offering.

Will collaborate with other member organizations to develop and expand open protocols, tooling, and best practices for ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath develops enterprise automation technology platforms; Robotic process automation enables digital workflow transformation; UiPath software integrates artificial i ...